复明治疗结节病的优点。

Medecine interne Pub Date : 1989-07-01
E Păunescu, C Didilescu, F Mihălţan, S Udrea, A Serbescu, M Dănălache-Dumitrescu, M Smărăndache, M Stoinescu, C Zaharescu, A Petre
{"title":"复明治疗结节病的优点。","authors":"E Păunescu,&nbsp;C Didilescu,&nbsp;F Mihălţan,&nbsp;S Udrea,&nbsp;A Serbescu,&nbsp;M Dănălache-Dumitrescu,&nbsp;M Smărăndache,&nbsp;M Stoinescu,&nbsp;C Zaharescu,&nbsp;A Petre","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Favourable results were obtained by treatment with Reprimun alone or in association with low doses of Prednisone in 112 patients with sarcoidosis (59% with active sarcoidosis and 33% failures of a previous corticotherapy). Treatments were applied during 3-6 series each one of 6 weeks at intervals of 2 weeks between series. In comparison with the classical corticotherapy, treatment with Reprimun has better results, namely: absence of any major adverse reactions; reduction of the treatment period to 6-12 months (3-6 series); 95% lasting remissions in the sarcoidoses with initial treatment and 78% remissions in the case of failures of a previous corticotherapy.</p>","PeriodicalId":76129,"journal":{"name":"Medecine interne","volume":"27 3","pages":"225-8"},"PeriodicalIF":0.0000,"publicationDate":"1989-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advantages of treatment with Reprimun in sarcoidosis.\",\"authors\":\"E Păunescu,&nbsp;C Didilescu,&nbsp;F Mihălţan,&nbsp;S Udrea,&nbsp;A Serbescu,&nbsp;M Dănălache-Dumitrescu,&nbsp;M Smărăndache,&nbsp;M Stoinescu,&nbsp;C Zaharescu,&nbsp;A Petre\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Favourable results were obtained by treatment with Reprimun alone or in association with low doses of Prednisone in 112 patients with sarcoidosis (59% with active sarcoidosis and 33% failures of a previous corticotherapy). Treatments were applied during 3-6 series each one of 6 weeks at intervals of 2 weeks between series. In comparison with the classical corticotherapy, treatment with Reprimun has better results, namely: absence of any major adverse reactions; reduction of the treatment period to 6-12 months (3-6 series); 95% lasting remissions in the sarcoidoses with initial treatment and 78% remissions in the case of failures of a previous corticotherapy.</p>\",\"PeriodicalId\":76129,\"journal\":{\"name\":\"Medecine interne\",\"volume\":\"27 3\",\"pages\":\"225-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medecine interne\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medecine interne","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在112例结节病患者(59%为活动性结节病,33%既往皮质治疗失败)中,单独使用remun或联合低剂量强的松治疗获得了良好的结果。治疗分3-6个系列进行,每个系列为6周,每个系列之间间隔2周。与经典的皮质疗法相比,remun治疗效果更好,即:无任何重大不良反应;将治疗期缩短至6-12个月(3-6个系列);经初始治疗的结节病有95%的持续缓解,在先前皮质治疗失败的情况下有78%的缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Advantages of treatment with Reprimun in sarcoidosis.

Favourable results were obtained by treatment with Reprimun alone or in association with low doses of Prednisone in 112 patients with sarcoidosis (59% with active sarcoidosis and 33% failures of a previous corticotherapy). Treatments were applied during 3-6 series each one of 6 weeks at intervals of 2 weeks between series. In comparison with the classical corticotherapy, treatment with Reprimun has better results, namely: absence of any major adverse reactions; reduction of the treatment period to 6-12 months (3-6 series); 95% lasting remissions in the sarcoidoses with initial treatment and 78% remissions in the case of failures of a previous corticotherapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信